Search Patents
  • Publication number: 20220076847
    Abstract: A microfluidic chip device includes a reservoir for holding a biologic sample containing a predetermined biologic material. A first plurality of parallel pathways each testing one of one or more treatment-agents and analyzing a first efficacy for each of the one or more treatment agents applied to the predetermined biologic material within the biologic sample. A multiplexer provides a portion of the biologic sample into each of the first plurality of parallel pathways from the reservoir. A second plurality of parallel pathways each test a plurality of different dosage levels of the one or more treatment agents and analyzes a second efficacy of the plurality of different dosage levels with respect to the predetermined biologic material. The multiplexer further provides a second portion of the biologic sample into a selected at least one of the second plurality of parallel pathways responsive to a control input indicating the treatment agent providing a highest efficacy.
    Type: Application
    Filed: November 3, 2021
    Publication date: March 10, 2022
    Inventors: JOVAN HUTTON PULITZER, HENRY JOSEPH LEGERE, III
  • Publication number: 20220415512
    Abstract: A method of signaling a medical response action comprises receiving a biofluidic input from a client or application, by a logical testing unit, wherein the logical testing unit comprising a testing display and a persistent testing mechanism, further wherein the persistent testing mechanism comprising one or more analogical data processors, generating one or more logical results from the processing of biofluidic data from the biofluidic input, displaying, on the testing display of the logical testing unit, the one or more logical results, capturing the logical indicators on the testing display with a mobile computing unit, generating, by the mobile computing unit, a pixelated result and an action result, displaying, on the mobile display, the pixelated result and action result, responsive to a signaling input from the client or application, the mobile computing unit processes, by one or more processors, the signaling input and generating an action response packet.
    Type: Application
    Filed: September 6, 2022
    Publication date: December 29, 2022
    Inventors: Jovan Hutton PULITZER, Henry Joseph LEGERE, III
  • Publication number: 20160371445
    Abstract: A method for adjudicating reimbursement for venom derived allergens between a pharmacist and a reimbursing entity comprises obtaining National Drug Codes (NDC's) for a plurality of venom derived allergens, storing in a central control database the obtained NDC's in association with an associated AWP and associated information for the venom derived allergen, which associated information includes translation information to allow practitioners to determine from a desired diluted level and number of doses of a desired NDC carrying venom derived antigen and a known dilution procedure how to translate back to the amount of base concentration of the NDC carrying venom derived antigen used to create the desired diluted level and number of doses, and determining if any of the NDC's in the central control database are contained within the third-party database and, if not, transferring the associated NDC's not in the third-party database to the third-party database.
    Type: Application
    Filed: August 11, 2016
    Publication date: December 22, 2016
    Inventors: JAMES STRADER, JOVAN HUTTON PULITZER
  • Publication number: 20170039346
    Abstract: A method for delivering an immunomodulator to a patient includes providing a bottle of concentrated immunomodulator extract; progressively diluting the antigen extract in sterile bottles; selecting a prescribed amount from a desired one of the dilution bottles; providing a viscous encapsulation material that is able to introduce antigens contained therein through the skin of a patient; introducing one or more doses of the selected prescribed amount of diluted immunomodulator into the viscous encapsulation material; disposing a prescribed amount of viscous encapsulation material containing the introduced diluted immunomodulator therein within a container that is able to dispense such viscous encapsulation material containing the introduced diluted immunomodulator; dispensing from the container the amount of viscous encapsulation material containing the diluted immunomodulator in an amount equal to a single dose; and applying the dispensed viscous encapsulation material containing the introduced diluted immunom
    Type: Application
    Filed: October 7, 2016
    Publication date: February 9, 2017
    Inventors: JAMES STRADER, JOVAN HUTTON PULITZER
  • Publication number: 20190376966
    Abstract: A system for providing colorimetric and ratiometric comparison and quantification for medical test results, comprising a testing device including an alignment target and including a plurality of immunoassay test strips, the plurality of immunoassay test strips each including a test line and a control line, and a colorimetry device configured to operate with a mobile device, the mobile device including a camera and a software application stored thereon, wherein the software application provides executable instructions to detect color properties of a color of the test line and a color of a control line of at least one of the plurality of immunoassay test strips, determine a risk value for each of at least one disease risks tested using the biologic sample, wherein the risk value is a rating determined from the color properties of the color of the test line, and provide medical test results based on the risk value.
    Type: Application
    Filed: June 6, 2018
    Publication date: December 12, 2019
    Inventors: JOVAN HUTTON PULITZER, HENRY JOSEPH LEGERE, III
  • Publication number: 20190099117
    Abstract: A vibrating finger cuff for use in performing a finger prick comprises a body having a first end and a second end, wherein the first end having a first opening and the second end having a second opening, and wherein a finger is inserted into the first opening until the finger exits the hollow body at the second opening, a housing secured to an outside surface of the hollow body, the housing including within a vibrator motor, a negative battery contact, a switch contact, a negative motor wire connected between the vibrator motor and the negative battery contact, a positive motor wire connected between the vibrator motor and the switch contact, and a battery housing containing a battery and a positive battery contact, wherein the positive battery contact extends upward from the battery housing so that it contacts the switch contact, and wherein the negative battery contact contacts the battery.
    Type: Application
    Filed: September 20, 2018
    Publication date: April 4, 2019
    Inventors: JOVAN HUTTON PULITZER, HENRY JOSEPH LEGERE, III
  • Patent number: 9857372
    Abstract: A system for providing immunoassay test results for multiple medical conditions, comprising a testing device having thereon an alignment target and having a plurality of immunoassay test strips, the plurality of immunoassay test strips each including a sample pad capable of receiving a biologic sample, a conjugate pad containing particles for conjugating with antibodies or antigens present in the biologic sample, and a membrane strip having a test line and a control line, wherein the test line and the control line are viewable, and a mobile device having a camera, a viewing screen, and a software application stored thereon, wherein the software application provides executable instructions to capture an image of the testing device, process an image to determine pixel count and line intensity of the test line of each of the plurality of immunoassay test strips, and present test results on the viewing screen.
    Type: Grant
    Filed: October 17, 2016
    Date of Patent: January 2, 2018
    Assignee: Reliant Immune Diagnostics, LLC
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • Patent number: 11802868
    Abstract: A method for providing variable function medical tests, comprising providing by a mobile device application a plurality of selectable medical test functions, receiving information from the mobile device application regarding test results from a test performed using a testing device, wherein the testing device includes an alignment target disposed on the testing device and a plurality of immunoassay test strips receiving at the server an image of the testing device from the mobile device application, determining by the server RGB values for a plurality of pixels of the image, normalizing by the server the RGB values into a single value, comparing by the server the single value to a control value stored on the server, and providing by the server a risk indicator, wherein the risk indicator indicates a likelihood of a presence of a medical condition.
    Type: Grant
    Filed: November 6, 2017
    Date of Patent: October 31, 2023
    Assignee: RELIANT IMMUNE DIAGNOSTICS, INC.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • Patent number: 11200986
    Abstract: A method for generating medical trends based on medical test results by a server, comprising obtaining results from a first test related to a medical condition of a first patient, obtaining results from a second test related to a medical condition second patient, wherein the results include patient information and efficacy and dosage level information of a medication, comparing the patient information and the test results of the first patient with the patient information and the test results of the second patient, determining that a patient characteristic of the first patient matches a patient characteristic of the second patient, storing a potential trend, receiving a plurality of additional test results, determining that the potential trend is found in the additional test results in an amount that is above a threshold, and altering the potential trend to an active trend.
    Type: Grant
    Filed: November 10, 2018
    Date of Patent: December 14, 2021
    Assignee: RELIANT IMMUNE DIAGNOSTICS, INC.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • Patent number: 11882628
    Abstract: A method is provided for interacting with audience members in an event, each of the potential attendees having available thereto a unique identifier. The method comprises creating, for an attendee, a unique ID (UID) on a mobile wireless device (MWD) by the steps of inputting to the MWD one of the unique identifiers, combining the obtained unique identifier with a UID time stamp at the time of creation of the UID; receiving with a server on a first wireless channel communications from the MWD; registering the UID at the physical location of the event; generating a visual query; displaying on the MWD response indicators; receiving at the server from the registered attendee a response, to the query over the first wireless channel; and storing in a database on the server the received response in association with the displayed query.
    Type: Grant
    Filed: August 3, 2022
    Date of Patent: January 23, 2024
    Assignee: Tesla Laboratories, LLC
    Inventor: Jovan Hutton Pulitzer
  • Patent number: 11651866
    Abstract: A method for initiating a telemedicine conference on a mobile device is provided. The method comprises receiving diagnostic test results in response to a diagnostic test, determining if the diagnostic test results include a positive result, storing the diagnostic test results on a server disposed on a network, presenting, if the diagnostic test results are positive, a telemedicine initiation option on a screen of the mobile device, determining whether the telemedicine initiation option is selected, sending the diagnostic test results from the server to the telemedicine provider, sending additional medical history information to the telemedicine provider, and initiating a telemedicine conference with the telemedicine provider. Some of these aspects also provide healthcare providers the ability to electronically send prescriptions and provide users the ability to use a mobile application to send prescriptions to pharmacies to be filled.
    Type: Grant
    Filed: September 20, 2018
    Date of Patent: May 16, 2023
    Assignee: RELIANT IMMUNE DIAGNOSTICS, INC.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • Patent number: 10524309
    Abstract: A method is provided for interacting with audience members in an event, each of the potential attendees having available thereto a unique identifier. The method comprises creating, for an attendee, a unique ID (UID) on a mobile wireless device (MWD) by the steps of inputting to the MWD one of the unique identifiers, combining the obtained unique identifier with a UID time stamp at the time of creation of the UID; receiving with a server on a first wireless channel communications from the MWD; registering the UID at the physical location of the event; generating a visual query; displaying on the MWD response indicators; receiving at the server from the registered attendee a response, to the query over the first wireless channel; and storing in a database on the server the received response in association with the displayed query.
    Type: Grant
    Filed: January 8, 2019
    Date of Patent: December 31, 2019
    Assignee: TESLA LABORATORIES, LLC
    Inventor: Jovan Hutton Pulitzer
  • Patent number: 11103178
    Abstract: An access system has a scanner that scans a unique identifier to access a location. A display receives an input. An automated dispenser dispenses at least one scent on each hand of an individual responsive to a control signal. A processor controls access to the location. A memory stores a set of instructions that configures the processor to receive the unique identifier from the scanner, actuate the automated dispenser to dispense the at least one scent responsive to receipt of the unique identifier, receive the response input based on the scents detected by the individual of the at least one scent, determine a passing result or a failing result responsive to the received response input and an expected response based on the dispensed at least one scent, enable access to the location responsive to a passing result and deny access to the controlled access location responsive to a failing result.
    Type: Grant
    Filed: February 24, 2021
    Date of Patent: August 31, 2021
    Assignee: Avrio Genetics
    Inventors: George Buckler, Jovan Hutton Pulitzer, James Strader, Brandon Hensinger
  • Publication number: 20230042512
    Abstract: A method for creating a consolidated compound for delivering an immunomodulatory and imiquimod to a patient, comprising diluting immunomodulator extract to a desired dilution by transferring a desired quantity of the concentrated immunomodulator to an associated sterile container, the associated sterile container having a defined volume of diluted immunomodulator after dilution thereof, providing a viscous encapsulation material, selecting a prescribed amount of concentrated immunomodulator, the prescribed amount defined as that amount of the diluted immunomodulator extract required to provide a number of doses equal to the number of dispensable increments from the container containing the viscous encapsulation material, introducing the selected amount of each of the diluted immunomodulator extract into the viscous encapsulation material, introducing an amount of imiquimod into the viscous encapsulation material, and mixing the introduced amount of each of the diluted immunomodulator extracts and the introduc
    Type: Application
    Filed: June 28, 2022
    Publication date: February 9, 2023
    Inventors: James STRADER, Jovan Hutton PULITZER
  • Patent number: 10473659
    Abstract: An immediate health assessment response system, comprising a testing device having thereon an alignment target and having a plurality of immunoassay test strips, the plurality of immunoassay test strips each including a sample pad capable of receiving a biologic sample, and a server configured to receive information from a mobile device regarding test results from a test performed using the testing device, receive an image from a mobile device, process the image to determine results based on pixel count and line intensity of the test line of each of the plurality of immunoassay test strips, compare the results of processing the image to a control for each test line of each of the plurality of immunoassay test strips, and provide a risk indicator, wherein the risk indicator alerts a user to seek medical attention immediately.
    Type: Grant
    Filed: October 17, 2017
    Date of Patent: November 12, 2019
    Assignee: Reliant Immune Diagnostics, Inc.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • Publication number: 20230005581
    Abstract: A method for delivering an immunomodulator to a patient includes providing a bottle of concentrated immunomodulator extract; progressively diluting the antigen extract in sterile bottles; selecting a prescribed amount from a desired one of the dilution bottles; providing a viscous encapsulation material that is able to introduce antigens contained therein through the skin of a patient; introducing one or more doses of the selected prescribed amount of diluted immunomodulator into the viscous encapsulation material; disposing a prescribed amount of viscous encapsulation material containing the introduced diluted immunomodulator therein within a container that is able to dispense such viscous encapsulation material containing the introduced diluted immunomodulator; dispensing from the container the amount of viscous encapsulation material containing the diluted immunomodulator in an amount equal to a single dose; and applying the dispensed viscous encapsulation material containing the introduced diluted immunom
    Type: Application
    Filed: February 14, 2022
    Publication date: January 5, 2023
    Inventors: James STRADER, JOVAN HUTTON PULITZER
  • Publication number: 20210090702
    Abstract: A method for a microfluidic testing device includes pumping a portion of a biologic sample into each of a first plurality of parallel pathways from the first reservoir using a micro-pump, applying a separate treatment agent of the plurality of treatment agents within each of the first plurality of parallel pathways to the portion of the biologic sample within the parallel pathway, pumping a second portion of the biologic sample into a selected second parallel pathway associated with a determined treatment agent of a second plurality of parallel pathways from the first reservoir using a second micro-pump, applying the determined treatment agent at a plurality of different dosage levels within the selected second parallel pathway to the second portion of the biologic sample within the selected second parallel pathway, and determining a dosage level of the plurality of different dosage levels of the determined treatment agent providing the treatment efficacy.
    Type: Application
    Filed: December 9, 2020
    Publication date: March 25, 2021
    Inventors: Jovan Hutton PULITZER, Henry Joseph LEGERE, III
  • Publication number: 20180166155
    Abstract: A method for correlating a retail testing product to medical codes is provided. The method comprises receiving a diagnostic test identifier at a server disposed on a network, retrieving a first medical code from a database, wherein the first medical code is associated with the diagnostic test identifier and the retail testing product, processing an image of the retail testing product to determine results of the test, retrieving a second medical code from the database, wherein the second medical code is associated with the test results, determining a recommended pharmaceutical product useful in treatment of at least one medical condition associated with the retail testing product, retrieving a third medical code from the database, where the third medical code is associated with the recommended pharmaceutical product, and transmitting the first medical code, the second medical code, and the third medical code to a healthcare entity.
    Type: Application
    Filed: December 14, 2017
    Publication date: June 14, 2018
    Inventors: JOVAN HUTTON PULITZER, HENRY JOSEPH LEGERE, III
  • Patent number: 11135332
    Abstract: A system for chemosensory disorder testing includes a scanner for scanning a unique identifier associated with a test subject. A scent dispensing unit dispenses a predetermined scent for the test subject responsive to receipt of a dispensing control signal. A user interface receives a test response input from the test subject based on a perception of the test subject of the predetermined scent dispensed by the scent dispensing unit. A central controller generates the dispensing control signal responsive to the unique identifier scanned by the scanner. The central controller further determines at least one of a pass test result or a fail test result responsive to a comparison of the test response input to a predetermined response associated with the predetermined scent. A relational database stores the pass test result or the fail test result at a location associated with the unique identifier associated with the test subject.
    Type: Grant
    Filed: February 24, 2021
    Date of Patent: October 5, 2021
    Assignee: Avrio Genetics
    Inventors: George Buckler, Jovan Hutton Pulitzer, James Strader, Brandon Hensinger
  • Patent number: 11567070
    Abstract: A method for collection and dissemination of biologic data, comprising collecting at least one biologic sample by a testing device including thereon an alignment target and including a plurality of immunoassay test strips, wherein the at least one biologic sample contacts a sample pad on at least one of the plurality of immunoassay test strips, assigning correlative values as test results, wherein each test performed on the biologic sample is assigned a different correlative value, receiving the test results at a server disposed on a network, wherein the server has configured thereon a database, assigning a unique identification to the biologic sample, storing the unique identification in the database, storing the test results in the database in association with the unique identification of the biologic sample, and providing access to the database to healthcare organizations for analysis of the test results.
    Type: Grant
    Filed: October 17, 2017
    Date of Patent: January 31, 2023
    Assignee: RELIANT IMMUNE DIAGNOSTICS, INC.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
Narrow Results

Filter by US Classification